These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

904 related items for PubMed ID: 31493951

  • 1. Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers.
    Sitt T, Kenney M, Barrera J, Pandya M, Eckstrom K, Warner M, Pacheco JM, LaRocco M, Palarea-Albaladejo J, Brake D, Rieder E, Arzt J, Barlow JW, Golde WT.
    Vaccine; 2019 Sep 30; 37(42):6221-6231. PubMed ID: 31493951
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model.
    Neilan JG, Schutta C, Barrera J, Pisano M, Zsak L, Hartwig E, Rasmussen MV, Kamicker BJ, Ettyreddy D, Brough DE, Butman BT, Brake DA.
    BMC Vet Res; 2018 Aug 29; 14(1):254. PubMed ID: 30157853
    [Abstract] [Full Text] [Related]

  • 3. Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine.
    Barrera J, Schutta C, Pisano M, Grubman MJ, Brake DA, Miller T, Kamicker BJ, Olutunmbi F, Ettyreddy D, Brough DE, Butman BT, Neilan JG.
    Vaccine; 2018 Feb 14; 36(8):1078-1084. PubMed ID: 29358056
    [Abstract] [Full Text] [Related]

  • 4. Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge.
    Schutta C, Barrera J, Pisano M, Zsak L, Grubman MJ, Mayr GA, Moraes MP, Kamicker BJ, Brake DA, Ettyreddy D, Brough DE, Butman BT, Neilan JG.
    Vaccine; 2016 Jun 08; 34(27):3214-3220. PubMed ID: 26707216
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine.
    Barrera J, Brake DA, Schutta C, Ettyreddy D, Kamicker BJ, Rasmussen MV, Bravo de Rueda C, Zurita M, Pisano M, Hurtle W, Brough DE, Butman BT, Harper BG, Neilan JG.
    Vaccine; 2018 Nov 19; 36(48):7345-7352. PubMed ID: 30327212
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in Cattle.
    Medina GN, Montiel N, Diaz-San Segundo F, Sturza D, Ramirez-Medina E, Grubman MJ, de los Santos T.
    Clin Vaccine Immunol; 2015 Nov 25; 23(2):125-36. PubMed ID: 26607309
    [Abstract] [Full Text] [Related]

  • 8. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
    Moraes MP, Segundo FD, Dias CC, Pena L, Grubman MJ.
    Vaccine; 2011 Nov 28; 29(51):9431-40. PubMed ID: 22027486
    [Abstract] [Full Text] [Related]

  • 9. Safety profile of a replication-deficient human adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle.
    Barrera J, Brake DA, Kamicker BJ, Purcell C, Kaptur R, Schieber T, Lechtenberg K, Miller TD, Ettyreddy D, Brough DE, Butman BT, Colby M, Neilan JG.
    Transbound Emerg Dis; 2018 Apr 28; 65(2):447-455. PubMed ID: 29076657
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattle.
    Steigerwald R, Brake DA, Barrera J, Schutta CJ, Kalla M, Wennier ST, Volkmann A, Hurtle W, Clark BA, Zurita M, Pisano M, Kamicker BJ, Puckette MC, Rasmussen MV, Neilan JG.
    Vaccine; 2020 Jan 22; 38(4):769-778. PubMed ID: 31718901
    [Abstract] [Full Text] [Related]

  • 11. Recombinant adenovirus co-expressing capsid proteins of two serotypes of foot-and-mouth disease virus (FMDV): in vitro characterization and induction of neutralizing antibodies against FMDV in swine.
    Wu Q, Moraes MP, Grubman MJ.
    Virus Res; 2003 Jun 22; 93(2):211-9. PubMed ID: 12782369
    [Abstract] [Full Text] [Related]

  • 12. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ.
    Biologicals; 2005 Dec 22; 33(4):227-34. PubMed ID: 16289996
    [Abstract] [Full Text] [Related]

  • 13. An adenovirus vectored mucosal adjuvant augments protection of mice immunized intranasally with an adenovirus-vectored foot-and-mouth disease virus subunit vaccine.
    Alejo DM, Moraes MP, Liao X, Dias CC, Tulman ER, Diaz-San Segundo F, Rood D, Grubman MJ, Silbart LK.
    Vaccine; 2013 Apr 26; 31(18):2302-9. PubMed ID: 23499593
    [Abstract] [Full Text] [Related]

  • 14. Recombinant adenovirus expressing type Asia1 foot-and-mouth disease virus capsid proteins induces protective immunity against homologous virus challenge in mice.
    Zhou G, Wang H, Wang F, Yu L.
    Res Vet Sci; 2013 Jun 26; 94(3):796-802. PubMed ID: 23267820
    [Abstract] [Full Text] [Related]

  • 15. Human adenovirus-vectored foot-and-mouth disease vaccines: establishment of a vaccine product profile through in vitro testing.
    Brake DA, McIlhaney M, Miller T, Christianson K, Keene A, Lohnas G, Purcell C, Neilan J, Schutta C, Barrera J, Burrage T, Brough DE, Butman BT.
    Dev Biol (Basel); 2012 Jun 26; 134():123-33. PubMed ID: 22888605
    [Abstract] [Full Text] [Related]

  • 16. A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles.
    Gullberg M, Lohse L, Bøtner A, McInerney GM, Burman A, Jackson T, Polacek C, Belsham GJ.
    PLoS One; 2016 Jun 26; 11(6):e0157435. PubMed ID: 27294397
    [Abstract] [Full Text] [Related]

  • 17. Adenovirus-vectored foot-and-mouth disease vaccine confers early and full protection against FMDV O1 Manisa in swine.
    Fernandez-Sainz I, Medina GN, Ramirez-Medina E, Koster MJ, Grubman MJ, de Los Santos T.
    Virology; 2017 Feb 26; 502():123-132. PubMed ID: 28039799
    [Abstract] [Full Text] [Related]

  • 18. Early detection and visualization of human adenovirus serotype 5-viral vectors carrying foot-and-mouth disease virus or luciferase transgenes in cell lines and bovine tissues.
    Montiel N, Smoliga G, Arzt J.
    Vaccine; 2012 Feb 21; 30(9):1690-701. PubMed ID: 22227230
    [Abstract] [Full Text] [Related]

  • 19. Evidence of partial protection against foot-and-mouth disease in cattle immunized with a recombinant adenovirus vector expressing the precursor polypeptide (P1) of foot-and-mouth disease virus capsid proteins.
    Sanz-Parra A, V Zquez B, Sobrino F, Cox SJ, Ley V, Salt JS.
    J Gen Virol; 1999 Mar 21; 80 ( Pt 3)():671-679. PubMed ID: 10092007
    [Abstract] [Full Text] [Related]

  • 20. Heterogeneity in the Antibody Response to Foot-and-Mouth Disease Primo-vaccinated Calves.
    Di Giacomo S, Brito BP, Perez AM, Bucafusco D, Pega J, Rodríguez L, Borca MV, Pérez-Filgueira M.
    Transbound Emerg Dis; 2015 Jun 21; 62(3):280-7. PubMed ID: 23895140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.